X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Aventis Pharma with Cadila Healthcare - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANOFI INDIA vs CADILA HEALTHCARE - Comparison Results

SANOFI INDIA    Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

CADILA HEALTHCARE 
   Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SANOFI INDIA CADILA HEALTHCARE SANOFI INDIA/
CADILA HEALTHCARE
 
P/E (TTM) x 31.0 35.8 86.5% View Chart
P/BV x 5.5 9.2 59.3% View Chart
Dividend Yield % 1.6 0.7 248.5%  

Financials

 SANOFI INDIA   CADILA HEALTHCARE
EQUITY SHARE DATA
    SANOFI INDIA
Dec-16
CADILA HEALTHCARE
Mar-16
SANOFI INDIA/
CADILA HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs4,560454 1,003.5%   
Low Rs4,400305 1,445.0%   
Sales per share (Unadj.) Rs1,028.596.1 1,070.3%  
Earnings per share (Unadj.) Rs129.014.9 867.1%  
Cash flow per share (Unadj.) Rs186.017.8 1,043.3%  
Dividends per share (Unadj.) Rs68.003.20 2,125.0%  
Dividend yield (eoy) %1.50.8 180.0%  
Book value per share (Unadj.) Rs753.652.3 1,441.6%  
Shares outstanding (eoy) m23.031,023.74 2.2%   
Bonus/Rights/Conversions -FV5:1-  
Price / Sales ratio x4.43.9 110.3%   
Avg P/E ratio x34.725.5 136.2%  
P/CF ratio (eoy) x24.121.3 113.2%  
Price / Book Value ratio x5.97.3 81.9%  
Dividend payout %52.721.5 245.1%   
Avg Mkt Cap Rs m103,174388,458 26.6%   
No. of employees `0003.615.4 23.5%   
Total wages/salary Rs m3,59213,317 27.0%   
Avg. sales/employee Rs Th6,537.76,371.1 102.6%   
Avg. wages/employee Rs Th991.4862.4 115.0%   
Avg. net profit/employee Rs Th819.8986.1 83.1%   
INCOME DATA
Net Sales Rs m23,68698,376 24.1%  
Other income Rs m708941 75.2%   
Total revenues Rs m24,39499,317 24.6%   
Gross profit Rs m5,28123,829 22.2%  
Depreciation Rs m1,3133,022 43.4%   
Interest Rs m15486 3.1%   
Profit before tax Rs m4,66121,262 21.9%   
Minority Interest Rs m0-300 0.0%   
Prior Period Items Rs m05 0.0%   
Extraordinary Inc (Exp) Rs m0-25 0.0%   
Tax Rs m1,6915,716 29.6%   
Profit after tax Rs m2,97015,226 19.5%  
Gross profit margin %22.324.2 92.0%  
Effective tax rate %36.326.9 135.0%   
Net profit margin %12.515.5 81.0%  
BALANCE SHEET DATA
Current assets Rs m15,67344,376 35.3%   
Current liabilities Rs m6,67834,071 19.6%   
Net working cap to sales %38.010.5 362.5%  
Current ratio x2.31.3 180.2%  
Inventory Days Days7654 141.1%  
Debtors Days Days2262 35.8%  
Net fixed assets Rs m8,09847,896 16.9%   
Share capital Rs m2301,024 22.5%   
"Free" reserves Rs m17,08848,746 35.1%   
Net worth Rs m17,35653,519 32.4%   
Long term debt Rs m08,964 0.0%   
Total assets Rs m25,400100,163 25.4%  
Interest coverage x311.744.7 696.6%   
Debt to equity ratio x00.2 0.0%  
Sales to assets ratio x0.91.0 94.9%   
Return on assets %11.815.7 74.9%  
Return on equity %17.128.4 60.1%  
Return on capital %26.934.3 78.6%  
Exports to sales %24.545.3 54.1%   
Imports to sales %28.05.9 471.5%   
Exports (fob) Rs m5,80144,537 13.0%   
Imports (cif) Rs m6,6275,838 113.5%   
Fx inflow Rs m7,14544,881 15.9%   
Fx outflow Rs m6,8469,069 75.5%   
Net fx Rs m29935,812 0.8%   
CASH FLOW
From Operations Rs m3,22619,938 16.2%  
From Investments Rs m-1,555-9,039 17.2%  
From Financial Activity Rs m-1,818-9,527 19.1%  
Net Cashflow Rs m-1471,372 -10.7%  

Share Holding

Indian Promoters % 0.0 74.8 -  
Foreign collaborators % 60.4 0.0 -  
Indian inst/Mut Fund % 14.4 8.3 173.5%  
FIIs % 14.6 5.9 247.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 10.5 11.0 95.5%  
Shareholders   15,184 44,069 34.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SANOFI INDIA With:   DR. REDDYS LAB  STERLING BIOTECH  JUBILANT LIFE SCIENCES  WYETH LTD  ABBOTT INDIA  

Compare SANOFI INDIA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades Marginally Lower; Auto Sector Witness Losses(11:30 am)

Share markets in India are presently trading marginally lower. Sectoral indices are trading on a mixed note with stocks in the auto sector and banking sector witnessing maximum selling pressure.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

Proxy Plays: A Smart Way to Bet on 'Off Limits' Companies(The 5 Minute Wrapup)

Aug 4, 2017

The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SANOFI INDIA SHARE PRICE


Aug 17, 2017 11:59 AM

TRACK SANOFI INDIA

  • Track your investment in SANOFI INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SANOFI INDIA 5-YR ANALYSIS

COMPARE SANOFI INDIA WITH

MARKET STATS